Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Phase II Study Of Pfizer Drug Meets Primary Endpoint
This article is from
The Cancer Letter
archive.
Vol. 32 No. 4 | April 24, 2009
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NCI Seeks $5.799 Billion In FY08 Bypass Budget
November 17, 2006
TCL Archive
Local Labs Not As Accurate As Central Testing For HER2
August 30, 2002
TCL Archive
Program Announcement On Effects Of Low Dose Radiation
October 2, 1981
TCL Archive
Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says
May 21, 1999
TCL Archive
RFP: Intellectual Property.
March 31, 2000
TCL Archive
NCI Supercomputer To Be Available To Extramural Scientists
June 8, 1984